China’s new commercial insurance model could broaden access to Alzheimer’s drugsnews2025-12-22T18:18:09+00:00December 22nd, 2025|Endpoints News|
Bristol Myers brings IRA drug pricing fight to Supreme Courtnews2025-12-22T18:04:49+00:00December 22nd, 2025|Endpoints News|
US charges six people with insider trading in case including Olema Oncologynews2025-12-22T17:43:48+00:00December 22nd, 2025|Endpoints News|
Ipsen gains access to ADC from Shanghai biotech Simcere Zaimingnews2025-12-22T14:12:36+00:00December 22nd, 2025|Endpoints News|
FDA approves Cytokinetics’ heart drug, giving it an edge over BMS rivalnews2025-12-19T22:01:44+00:00December 19th, 2025|Endpoints News|
White House unveils nine more ‘most favored nation’ dealsnews2025-12-19T19:19:36+00:00December 19th, 2025|Endpoints News|
BioMarin to pay $4.8B for Amicus and its rare disease drugsnews2025-12-19T16:10:45+00:00December 19th, 2025|Endpoints News|
US commission urges action as China’s biotech sector advancesnews2025-12-19T05:01:37+00:00December 19th, 2025|Endpoints News|
UK committee demands ‘much-needed clarity’ on UK-US pharma trade dealnews2025-12-19T00:01:46+00:00December 19th, 2025|Endpoints News|
Moderna lands CEPI as new backer for its pandemic flu programnews2025-12-18T12:00:43+00:00December 18th, 2025|Endpoints News|
